"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
B
HighReliability
B - HighIncorporation date
12/09/2002Share capital
6,050,000.00 PLNPrimary activity
Wholesale of pharmaceutical goods (46.46.Z - PKD 2007)Representatives
0Representatives rights
DO REPREZENTOWANIA SPÓŁKI UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
18,141,905Net Profit (zł)
18,141,905Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 683,972,067 |
| 7,360,943 |
| 5,615,539 |
| 0.06 |
| 1.16 |
| 0.82 |
| 42,187,231 |
| 240,290,478 |
| 0 |
| 0 |
| 2023 |
|---|
| 1,029,815,733 |
| 21,342,107 |
| 16,155,773 |
| 0.05 |
| 1.15 |
| 1.57 |
| 58,343,004 |
| 382,144,441 |
| 0 |
| 0 |
| 2024 |
|---|
| 1,223,832,935 |
| 22,584,898 |
| 18,141,905 |
| 0.06 |
| 1.14 |
| 1.48 |
| 76,484,908 |
| 538,803,561 |
| 0 |
| - |
| 2024 |
|---|
| 1,223,832,935 |
| 22,584,898 |
| 18,141,905 |
| 0.06 |
| 1.14 |
| 1.48 |
| 76,484,908 |
| 538,803,561 |
| 0 |
| - |
Turnover (zł)
2024
Turnover (zł)
1,223,832,935 zł
19 % *
Profit before tax (zł)
22,584,898 zł6 % *
Net Profit (zł)
18,141,905 zł12 % *
Working capital requirement (%)
0.06 
20.00 % *
Liquidity ratio
1.14 
-0.87 % *
Net profitability (%)
1.48 %-5.73 % *
Equity (zł)
76,484,908 zł31 % *
Current liabilities (zł)
538,803,561 zł41 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
12/06/2025 | OD 01.01.2024 DO 31.12.2024 |
01/07/2024 | OD 01.01.2023 DO 31.12.2023 |
06/06/2023 | OD 01.01.2022 DO 31.12.2022 |
31/08/2022 | OD 01.01.2021 DO 31.12.2021 |
01/07/2021 | OD 01.01.2020 DO 31.12.2020 |